Prognostic markers in the pathology of cardiac failure: echocardiography and autonomic nervous system dysfunction

Elena Cristina Enciu1, Silviu Marcel Stanciu, Dumitru Matei

  • 1Laboratory of Cardiovascular Noninvasive Investigations, "Dr. Carol Davila" Central Military University Hospital, Bucharest, Romania; silviu.stanciu@yahoo.com.

Insights

Echocardiography offers key insights into chronic heart failure prognosis. Combining imaging with functional tests like autonomic nervous system dysfunction assessment improves patient management and predicts cardiac events.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Heart Failure Research

Background:

  • Chronic heart failure (CHF) remains a significant global health challenge with high mortality and morbidity despite advancements.
  • Echocardiography is the standard for assessing left ventricular function and can predict future heart failure events.

Purpose of the Study:

  • To comprehensively review echocardiographic markers for diagnosing and managing chronic heart failure.
  • To highlight the prognostic value of various echocardiographic parameters and emerging markers.

Main Methods:

  • Analysis of key echocardiographic markers: ejection fraction, diastolic impairment, and inferior vena cava collapse.
  • Inclusion of autonomic nervous dysfunction as a marker for cardiac events.
  • Discussion of Tissue Doppler Imaging and heart rate recovery as advanced prognostic indicators.

Main Results:

  • Left ventricle ejection fraction is commonly used but may not be sufficient for comprehensive prognostic assessment.
  • Newer parameters like Tissue Doppler Imaging and heart rate recovery show promise for improved prediction.
  • Autonomic nervous dysfunction is recognized as a significant marker for future cardiac events.

Conclusions:

  • No single marker can fully assess cardiac failure; each parameter has limitations.
  • Echocardiography provides essential morphological data that must be integrated with clinical and functional assessments.
  • Correlating echocardiographic findings with exercise stress tests and autonomic nervous system dysfunction is crucial for optimal patient management.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
738
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
771
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
610